The biologics fill / finish services market is projected to reach over USD 10 billion by 2030, growing at an annualized rate of 10%, claims Roots Analysis
May 25, 2021 10:00 ET
|
Roots Analysis
London, May 25, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Biologics Fill / Finish Services Market (2nd Edition) 2021 – 2030” report to its list of offerings. In pursuit...
The viral and non-viral vector manufacturing market is projected to grow at an annualized rate of over 15%, claims Roots Analysis
May 06, 2021 08:45 ET
|
Roots Analysis
London, May 06, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market (4th Edition) 2021 – 2030” report to its...
The targeted protein degradation enabling technologies market, featuring a healthy pipeline of novel therapeutics, is anticipated to be worth over USD 3.3 billion by 2030, predicts Roots Analysis
May 04, 2021 10:00 ET
|
Roots Analysis
London, May 04, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Targeted Protein Degradation Market, 2021-2030” report to its list of offerings. Small-molecule-induced...
The CAR-T therapies market is characterized by a healthy pipeline of promising therapies, and is projected to be worth around USD 14 Billion in 2030, claims Roots Analysis
April 06, 2021 08:45 ET
|
Roots Analysis
London, April 06, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “CAR-T Therapies Market (3rd Edition) by Target Indications (NHL, Multiple Myeloma, Chronic Lymphocytic...
The real world evidence (RWE) market is projected to be worth USD 4.5 billion by 2030, growing at a CAGR of 15%, claims Roots Analysis
March 03, 2021 08:45 ET
|
Roots Analysis
London, March 03, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Pharmaceutical and Life Sciences Real World Evidence Market, (2nd Edition), 2021-2030” report to its list of...
The T-cell immunotherapy market is projected to grow at an annualized rate of 12.2%, claims Roots Analysis
February 11, 2021 12:03 ET
|
Roots Analysis
London, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Global T-Cell (CAR-T, TCR, and TIL) Therapies Market (5th Edition)-Distribution by Type of Therapy (CAR-T, TCR...
The global mRNA therapeutics and vaccines market is projected to be worth around USD 10 billion in 2021, claims Roots Analysis
February 09, 2021 09:12 ET
|
Roots Analysis
London, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “mRNA Therapeutics and Vaccines Market, 2020-2030” report to its list of offerings. With over 150 candidates...
Growing at an annualized rate of over 12%, the ADC contract manufacturing market is estimated to reach close to USD 3 Billion by 2030, claims Roots Analysis
February 04, 2021 11:00 ET
|
Roots Analysis
London, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “ADC Contract Manufacturing Market (4th Edition), 2020-2030” report to its list of offerings. Manufacturing of...
The gene therapy market is projected to be worth USD 14.6 billion in 2030, growing at a CAGR of 30%, over the next decade, claims Roots Analysis
February 02, 2021 11:19 ET
|
Roots Analysis
London, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Gene Therapy Market (4th Edition), 2020-2030” report to its list of offerings. Success of approved gene...
The market for 3D cell culture products is estimated to be worth USD 6.8 Billion by 2030, growing at an annualized rate of over 15.5%, claims Roots Analysis
November 24, 2020 08:30 ET
|
Roots Analysis
London, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “3D Cell Culture Market” report to its list of offerings. Over the years, various industry stakeholders...